Eflapegrastim

Eflapegrastim Uses, Dosage, Side Effects, Food Interaction and all others data.

Eflapegrastim is under investigation in clinical trial NCT02953340 (Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Early- Stage BReast Cancer Patients Receiving Docetaxel and Cyclophosphamide (RECOVER)).

Trade Name Eflapegrastim
Generic Eflapegrastim
Eflapegrastim Other Names Eflapegrastim
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Eflapegrastim
Eflapegrastim

Innovators Monograph

You find simplified version here Eflapegrastim

*** Taking medicines without doctor's advice can cause long-term problems.
Share